Company intelligence / Profile preview

Sterling Organics

Newcastle upon Tyne, Tyne and Wear, United Kingdom

Ownership: Private
Development stage: Other

Overview

Sterling Organics was a prominent British manufacturer of fine chemicals and active pharmaceutical ingredients (APIs), most notably paracetamol. Based in Fawdon, Newcastle upon Tyne, the company served as the chemical manufacturing arm of Sterling Drug (Sterling Winthrop). Over several decades, the company underwent multiple ownership changes, being acquired by Eastman Kodak, Sanofi, and ChiRex. Today, its legacy and manufacturing facilities continue through Sterling Pharma Solutions, a leading global CDMO. The company was historically significant for its large-scale production of analgesics and various pharmaceutical intermediates.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Sterling Organics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sterling Organics.

Explore the full profile